Introduction
During early embryonic development, the mesodermal cells become sequentially determined to more precisely defined cell fates and give rise to a diverse array of functional somatic cell types including muscles, heart, vasculature, blood, kidney, gonads, dermis and cartilage. Understanding of the differentiation process by which mesodermal cells are patterned into diverse somatic cells demands an in-depth analysis of the endogenous signaling cascades and transcription factor networks (Willems & Leyns 2008) . Till now, this fascinating puzzle is not yet solved, because isolation of pure mesodermal cells from early-stage embryos in sufficient quantities was not feasible because of technical limitations, and hence the functional genomics of the mesodermal cells has not yet been successfully explored. This has caused a hindrance in our understanding on the patterning of mesoderm into its specific lineages and an impedance to the embryonic ⁄ induced pluripotent stem cell-based cell replacement therapy to treat several degenerative diseases. Embryonic stem cells (ESCs) have been proven to be a promising tool to study the early embryonic development in a more physiological context in vitro because of their versatility over other conventional systems (Doss et al. 2004; Gadue et al. 2005; Winkler et al. 2005) .
In mouse embryo, mesoderm is generated from the epiblast through the process of gastrulation that is initiated at approximately day 6.5 of gestation (Tam & Behringer 1997; Baron 2005) . Brachyury (also known as T) is considered to be one of the best markers of early pan-mesoderm and is used widely in the field of developmental biology to track the development of this germ layer (Kispert & Hermann 1993; Lacaud et al. 2004) . It is expressed in all nascent mesoderm and down-regulated as these cells undergo patterning and specification into the derivative tissues including skeletal muscle, cardiac muscle and connective tissues in addition to blood and endothelium (Herrmann 1991; Kispert & Herrmann 1994) .
To circumvent the practical difficulties in isolating in vivo brachyury-expressing cells in sufficient quantities during embryonic development, we used ESC model as an alternative approach. We established an ESC-derived transgenic brachyury cell line expressing bicistronically both puromycin-N-acetyltransferase and enhanced green fluorescent protein (EGFP) under the control of brachyury promoter with the help of an IRES element. We further identified the transcriptomic signatures of ESC-derived brachyury + cells. Finally, we investigated the functional relevance of two transcripts of unknown functions (TUFs), La ribonucleoprotein domain family, member 2 (Larp2) and ankyrin repeat domain 34B (Ankrd34b) in the differentiating embryoid bodies (EBs) by siRNA-mediated knockdown approaches.
Results

Isolation of brachyury + cells from the transgenic brachyury ESC line
The 4.5-kb brachyury promoter was isolated from the BAC clone containing brachyury gene using the recombineering approach as outlined in the scheme in the Fig. S1 . It was then subcloned in the ESC targeting construct pPuro IRES2 EGFP to get pTbra p Puro IRES2 EGFP. The brachyury ESC line was generated with the linearized pTbra p Puro IRES2 EGFP construct by stable transfection. EBs, when generated from the brachyury ESC clone applying the hanging drop protocol and analyzed at regular time intervals, showed the transient expression of brachyury transcripts as shown by RT-PCR (see Fig. 1a ). The ESCs and EBs from this transgenic clone behaved faithfully with the wild-type ES and EBs in terms of the brachyury expression and other germ layer-specific transcripts expression (data not shown). The brachyury expression is distributed uniformly throughout the EBs as evident from the EGFP expression in every EB as analyzed using confocal microscopy (see Fig. 1b ). Fluorescence-activated cell sorting (FACS) analysis of the EBs showed the same pattern of EGFP expression (Fig. 1c) as that of brachyury mRNA expression (Fig. 1a) . Application of puromycin with the experimental protocol outlined in Fig. 1d led to the enrichment of brachyury + cells in 6-day-old EBs up to 79% (hereafter called 'brachyury + cells'), compared to 1.4% in the puromycin-untreated control 6-day-old EBs from the same preparation (hereafter called 'control EBs') as analyzed by FACS (see Fig. 1e ). Under the same treatment regime, the wild-type EBs did not survive in puromycin selection implying the remaining 21% of the cells in the puromycin-treated EBs are brachyury positive at the time of puromycin selection which later down-regulated brachyury and hence EGFP expression at the end of puromycin selection protocol because of ongoing differentiation process. This finding is in association with the in vivo findings that the brachyury expression is very transient, and these cells undergo differentiation very dynamically. Furthermore, the enrichment of brachyury + cells was confirmed by immunohistochemistry for the coexpression of EGFP and brachyury (see Fig. 1f ).
Differentially expressed transcriptome in brachyury + cells
Transcriptomic profiling of the undifferentiated transgenic brachyury ESCs (hereafter called 'ESCs'), brachyury + cells and control EBs was carried out from three biologically independent set of experiments using the Affymetrix mouse MG 430 v2.0 3¢ oligonucleotide microarrays (Affymetrix UK Ltd, High Wycombe, UK). Raw expression results were Robust Multi-array Average (RMA)-normalized (Irizarry et al. 2003) . A parametric ANOVA (F-tests) and three pairwise comparisons using the least significant differences (LSD) post hoc test have been carried out on the transcriptome results obtained from ESCs, control EBs and brachyury + cells. The false discovery rate (FDR) of the F-test-set has been calculated using the Benjamini-Hochberg procedure (Hochberg & Benjamini 1990 ). An ANOVA FDR-value <10 )3 has been used to identify and restrict the number of 10 090 probe sets transcripts that were differentially expressed among the conditions day-0 undifferentiated ESCs, day-6 control EBs and day-6 brachyury + cells. Further filtering of the transcripts with LSD post hoc P < 0.01 (in each of conditions -in brachyury + cells vs. ESCs as well as in brachyury + cells vs. day 6 control EBs), a fold change cutoff of 2 and redundancies removal led to 3022 unique transcripts.
We verified the Affymetrix data by examining the expression levels of four randomly chosen representative genes namely Nanog, bone morphogenetic protein 2 (Bmp2), Sox17 and neurofilament H (Nefh) by applying the quantitative real-time PCR (qPCR) method. As indicated in Fig. S2 , results from the Affymetrix analyses clearly correspond to the results obtained from qPCR. Among them, 1573 transcripts were found to be up-regulated in brachyury + cells in comparison with at least one of the two control population, brachyury + ESCs, control EBs or both, and 1549 transcripts were down-regulated compared to both control populations as summarized in Fig. 2b . These transcripts were then further analyzed applying the Database for Annotation, Visualization and Integrated Discovery (DAVID) tool (Dennis et al. 2003) . As demonstrated, over 400 transcripts were identified to be involved in transcriptional processes (see Fig. 2b ). Interestingly, over 400 transcripts seem to be involved in the regulation of the developmental processes. Among them, 216 transcripts were identified to be up-regulated in brachyury + cells. Hierarchical clustering of these 216 up-regulated genes associated with development is shown in Fig. 2c . + embryonic stem cells (ESCs), control EBs or both and 1549 transcripts are down-regulated compared to both control populations (b) DAVID was used to obtain gene ontology biological processes annotations. The bar chart shows the number of genes in the categories adhesion, cell cycle, cell death, cell-cell signaling, cellular metabolism, development, stress response, signal transduction, transcription and transport separately for up-regulated and down-regulated transcripts. (c) Hierarchical clustering of probe sets identified as up-regulated and associated with 'developmental processes' in brachyury + at least twofold higher compared to either ESCs, control EBs or both. Each transcript is represented by a single row of colored boxes; each array is represented by a single column. Rectangles corresponding to intermediately expressed transcripts are colored black, up-regulated transcripts are indicated with red of increasing intensity, and weakly expressed transcripts with green of increasing intensity. To study the specific transcription regulatory mechanisms related to brachyury + cells, we obtained a list of the genes up-regulated in the BMP-2 + cells and myosin heavy chain a (a-MHC) + cells as reference sets from our previous published work (Doss et al. 2007a,b) . We used these reference data sets to eliminate the transcripts common to the late mesodermal ⁄ somatic lineages. We carried out binding site analysis in the promoters of the genes up-regulated specifically in the brachyury + cells (see Experimental procedures for the detailed analysis). When scanned through all the brachyury + cell-specific transcription factors in TRANSFAC Ò (version 11.4) (BIOBASE GmbH, Wolfenbüttel, Germany) (Wingender et al. 1996) and Jaspar (Sandelin et al. 2004 ) databases, two candidates qualifying most of our criteria of analysis were filtered out (see Fig. 3 ). Transfac motif M00242, peroxisome proliferator-activated receptor a (PPARa), scored over threshold 9.89 in 15 of 109 (13.8%) promoters of the brachyury + -specific list. Transfac motif M00258, interferon-sensitive response element (ISRE), scored over threshold 10.63 in 23.9% of the promoters in the brachyury + -specific genes. Target promoters of PPARa in the brachyury + -specific list were from genes AC158524.2, ACAA1B, ACTA1, ASPA, CDCP1, GPATCH2, HIST1H1C, MPZL3, PRDM8, RB1, SERPINB9B, SLC23A3, SLC7A6OS, SPRR2B and TBX18. Target promoters of ISRE in the brachyury + -specific list were from genes 5630401D24RIK, B230120H23RIK, CDK9, CXCL10, EPS8L2, F3, GBP1, GBP2, GPATCH2, H2-D1, H2-Q7, H2-Q8, H2-T3, HHIPL2, HIST1H1C, IL1RAP, LATS2, MARS, NEFM, PLK2, PPM1D, RIOK3, SER-PINB9B, SLC23A3, SMC5 and ZBTB4.
Transcriptome of brachyury + (T) cells
Functional evaluation of Larp2 and Ankrd34b, two TUFs specifically up-regulated in brachyury + cells
The selection criteria for the functional analysis of the TUFs for further investigation were as follows: (i) their functions should be unknown so far at least for their role in embryonic developmental context. (ii) TUFs should be up-regulated with high fold change compared to the ESCs and control EBs from the Affymetrix data (see Fig. 4 ). (iii) TUFs should be developmentally regulated in early embryos (see Fig. 4b ). (iv) TUFs should not have any information other than their conserved domain contained in their protein, if any. Accordingly, two TUFs, La ribonucleoprotein domain family, member 2 (Larp2) (also known as 1700108L22Rik) and ankyrin repeat domain 34B (Ankrd34b), were chosen after assessing fulfilment of the above criteria (see Fig. 4 ). As demonstrated in Fig. 4a , both transcripts are specifically up-regulated in brachyury + cells as well as in ES-derived BMP-2 + cells which represents late mesodermal cells (Doss et al. 2007a) in contrast to functional cardiovascular cell types such as cardiomyocytes (Doss et al. 2007b ) and contractile smooth muscle cells isolated from ESCs (Potta et al. 2009 ). Larp2 (http://www.ncbi.nlm. nih.gov/UniGene/clust.cgi?UGID=271837&TAXID =10090&SEARCH=mm.46782) encodes for an RNA-binding protein that is developmentally regulated in early murine embryonic stages (http://www. ncbi.nlm.nih.gov/sites/entrez?db=geo&cmd=search& term=1700108L22Rik). This transcript is up-regulated in preimplantation embryos. The function of this gene has not yet been reported. LA domain codes for a protein, which binds to RNA. Generally, the La protein plays a role in the transcription of RNA polymerase III. It is most probably a transcription termination factor. Normally, it binds to the 3¢ termini of virtually all nascent polymerase III transcripts. It is associated with precursor forms of RNA polymerase III transcripts including tRNA and 4.5S, 5S, 7S and 7-2 RNAs (by similarity).
Ankrd34b (UniGene Mm.213623, http://www. ncbi.nlm.nih.gov/UniGene/clust.cgi?ORG=Mm&CID =213623) is normally expressed during embryonic development in spinal cord belonging to the CNS (http://www.ncbi.nlm.nih.gov/geo/gds/profileGraph. cgi?&dataset=sztDAC&dataset=wywCBC$&gmin= 0.129683&gmax=2.000224&absc=&gds=2209&idref= 1435307_at&annot=Ankrd34b). The protein product of this transcript contains conserved domains for ankyrin-repeat domains. Ankyrin repeats mediate protein-protein interactions thereby modulating several biological processes such as differentiation (Hortsch et al. 2009 ). In this context, it has been demonstrated that interaction of L1-type cell adhesion molecules (CAMs) with ankyrins promotes neurogenesis (Hortsch et al. 2009). Ankyrins are also involved in the neurogenesis in zebrafish (Diks et al. 2006) and Xenopus neurogenesis (Lahaye et al. 2002) .
Both transcripts were functionally evaluated by systematic 'loss of function' studies using the siRNA knockdown approach. The relative mRNA expression levels of Nefh, brachyury, Bmp2, Sox17, Nanog, Oct4, Myh6, PPARc, NF-H (also known as Nefh) and PECAM1 were analyzed using qRT-PCR. Nefh, brachyury, Bmp2 and Sox17 are the canonical germ layer markers. Nanog and Oct4 are pluripotent ESCs markers. Myh6, PPARc, NF-H and PECAM1 are mesodermal-derived somatic cell markers for cardiac, adipogeneic, neurogeneic and endothelial cells, respectively. siRNA-transfected ESCs were monitored for any morphological changes associated with any differentiated cell types.
As shown in Fig. 5a -i, transfection by siRNA targeted against Larp2 resulted in more than 50% significant knockdown of Larp2 mRNA expression in undifferentiated ESCs (d0) at 24 h post-transfection. At 48-h post-transfection, the transfected undifferentiated ESCs were used for differentiation applying 'hanging drop' protocol, and then total RNA was isolated at regular intervals from 1 to 10 EBs. As 
expected, the expression remained still down-regulated in 1-9-day-old EBs (see Fig. 5a -ii) because of siRNA knockdown. The expression of pluripotent and germ layer representative genes was determined using the qRT-PCR. As shown in Fig. 5b , the BMP-2 expression level only at day 3 was significantly down-regulated, compared to vehicle-treated and untreated differentiated ESCs (see Fig. 5b ). No significant differences have been observed regarding the expression of NF-H, brachyury and Sox17 (see Fig. 5a ) and pluripotent markers Oct4 and Nanog as well as on the expression of the cardiomyocytes markers such as GATA4, Nkx2.5 and a-MHC (data not shown). As shown in Fig. 6a , transfection of the brachyury + cells with siRNA directed to Ankrd34b resulted in a significant knockdown of the Ankrd34b first detectable in 2-day-old EBs (80% inhibition of the mRNA expression) and a complete knockdown within the 3-day-old EBs compared to vehicletreated cells. Normal expression levels like in the vehicle-treated 4-day-old EBs have been observed in the 4-day-old EBs generated from siRNA-treated ESCs.
As demonstrated in Fig. 6b , the expression of NF-H in EBs generated with siRNA-treated cells was rapidly down-regulated in the 2-day-old EBs, (ii) 48 h after transfection (day 0 as per the differentiation protocol), the siRNA-transfected ESCs were used for making 'hanging drop' embryoid bodies (EBs). Upon isolation of total RNA, RT-PCR was carried out using the respective primers shown in Table S5 (see Experimental procedures). As an internal loading control, PCRs were carried out using the GAPDH primers (Table S5) . Diagram summarizes densitometric analysis of three independent experiments (mean ± SD, n = 3, *P < 0.05 for the siRNA-treated vs. vehicle-treated cells). (b) Effect of siRNA on gene expression of germ layers-specific genes in ESCs and EBs generated by the hanging drop protocol. After RNA isolation, the expression level was determined using qRT-PCR (for more details see Materials). Experiments were carried out in triplicates (mean ± SD, n = 3, *P < 0.05 for the siRNA-treated vs. untreated or vehicle-treated cells).
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Genes to Cells (2010) 15, 209-228 Journal compilation Ó 2010 by the Molecular Biology Society of Japan/Blackwell Publishing Ltd. compared to the high expression level of the NF-H in undifferentiated and in 1-day-to 4-day-old EBs. Furthermore, siRNA-treated ESCs and EBs showed higher PPARc expression levels compared to the respective vehicle-treated control ESC and EBs (Fig. 6c) . Also, the expression level of PECAM1 in EBs generated from siRNA-treated cells remained significantly higher between days 1 and 2 in comparison with that in vehicle-treated EBs (see Fig. 6d ). No differences in mRNA expression levels of the pluripotent marker genes (Oct4 and Nanog), mesodermal marker genes (brachyury and BMP-2), cardiomyocytes and endothelial marker genes between vehicle and siRNAtreated cells could be observed (see Fig. S4 ).
Discussion
Analysis of the genes differentially regulated in brachyury + cells
Evidently, GOs associated with differentiation and developmental processes as well as GOs associated with an increased transcriptional activity are highly enriched in genes up-regulated in the brachyury + cells (Table 1 ). These results demonstrate the high developmental capacity of brachyury + cells. Obviously, GOs associated with transcripts regulating apoptosis and cell death are also highly enriched. It is well known that apoptosis is one of the key biological Figure 6 Effect of siRNAs directed to ankyrin repeat domain 34B on specific gene expression markers in embryonic stem cells (ESCs). (a) Transfection of ESCs cultured in culture Petri-dishes (approximately 50% confluence) with the appropriate siRNA (100 nM) was carried out for 24 h. Upon isolation of total RNA, RT-PCR was carried out using the respective primers shown in additional data file 9 (see Experimental procedures). As an internal loading control, PCR reactions were carried out using the GAPDH primers (additional data file 9). Diagram summarizes densitometric analysis of three independent experiments (mean ± SD, n = 3, *P < 0.05 for the siRNA-treated vs. vehicle-treated cells). (b, c, d) Effect of siRNA on gene expression NFH expression PPARc and PECAM1, respectively, in ESCs and embryoid bodies generated by the hanging drop protocol. After RNA isolation the expression level was determined by RT-PCR (for more details see Materials). Experiments were carried out in triplicate (mean ± SD, n = 3, *P < 0.05 for the siRNA-treated vs. vehicle-treated cells).
processes regulating specific organ development such as cardiac and notochord development in vertebrates (Martinsen 2005; Malikova et al. 2007) . Interestingly, transcripts associated with mitogen-activated protein kinase (MAPK) SIGNALING Kyoto Encyclopedia of Genes and Genomes (KEGG) PATHWAY, p38 MAPK BIOCARTA pathway and the MAPKKK cascade GO biological process annotation (GO: 0000196) were found to be enriched in brachyury + cells. The MAPK pathway is speculated to promote inhibition of the self-renewal state of ESCs and is involved in the development of the early mesoderm differentiation. p38MAPK displays a large spectrum of action from neurons to the mesodermal-derived adipocytes [for review see (Binetruy et al. 2007) ]. Transcripts associated with transforming growth factor beta (TGFb) SIGNALING PATHWAY were also found to be enriched in brachyury + cells. TGFb superfamily plays a key role for the induction of mesoderm and endoderm (Shen 2007) . From these results, we might conclude that similarly to the in vivo situation similar signaling pathways are identified to be enriched in mesodermal brachyury + cells. Interestingly, Tbx6, Gm397, Lif, Follistatin and Wnt9a are all up-regulated in brachyury + cells in comparison with both ESCs and control EBs (Table S1 ). In this context, recently, it has been shown that Wnt signaling and Tbx6, a T-box transcription factor, regulate the presomitic mesoderm formation (Wittler et al. 2007; Dunty et al. 2008) . Follistatin is a BMP-2 antagonist that is required for formation of the neural plate and dorsal mesoderm (Khokha et al. 2005) . More recently, Gm397 has been identified to be a predominant transcript in ESCs and renamed as Zscan4c (Falco et al. 2007 ).
Promoter analysis of the transcripts upregulated in brachyury + cells
Transfac motifs M00242 peroxisome proliferator-activated receptor a (PPARa) and M00258 ISRE showed several fold enrichment in the brachyury + -specific list. Of these, ISRE is a strong inducer of apoptosis acting through expression of caspase 8 (Casciano et al. 2004 ). This finding is in accordance with our observation that the GOs containing genes regulating apoptosis and cell death are also highly enriched (see Table 1 ). PPARa belongs to the steroid hormone receptor superfamily and is involved in transcriptional regulation of genes regulating lipid metabolism, cell proliferation and cell differentiation. Recently, it has been shown that PPARa is involved also in cardiomyocytes differentiation of murine ESCs (Ding et al. 2007; Sharifpanah et al. 2008) .
As Larp2 is up-regulated only in the mesodermal brachyury and BMP-2 cell lineages (see Fig. 4a ) and also temporally and spatially regulated during mouse embryonic development (see Fig. 4b ), we assumed that the rest of the protein motif(s) apart from the La domain might play a role in the early developmental stage. Together, our findings from siRNA-mediated knockdown of Larp2 suggest that the Larp2 is positively involved in the regulation of BMP-2 expression. No differences in the morphology of the EBs were observed (data not shown). Interestingly, knockdown of Ankr34b led to significant changes in the expression patterns of NF-H, PPARc and PECAM1 on differentiation. NF-H is a pan-ectodermal marker (Petzold et al. 2007) . PPARc is an adipogenic marker (Szabo et al. 2008 ) and PECAM1, a haematopoietic and endothelial progenitor cell-specific marker (Ross et al. 2008; Mariappan et al. 2009 ).
To date, the role of Ankyrins in mesodermderived adipocytes and endothelial progenitor cells has not yet been reported. These results demonstrate a negative regulatory effect of the Ankrd34b gene on the expression of PPARc and PECAM1 and a positive regulatory role on the expression of NF-H. These results suggest that Ankrd34b might be a positive regulator of the ectoderm-dependent neurogenesis and negative regulator of the mesoderm-dependent adipogenesis and hematopoiesis. The present findings support also the observation that Ankyrins are involved in neurogenesis as observed as previously described (Lahaye et al. 2002; Diks et al. 2006; Hortsch et al. 2009 ). In conclusion, substantial attempts were made to identify the complete transcriptome of the brachyury + mesodermal cells and to address the role of two TUFs in terms of their possible role in regulation of key genes involved in germ layer and somatic cell development. The transcriptomic analysis of the brachyury + cells reported here defines the cellular and genetic identities of the mesodermal cells for the first time. Moreover, this will in turn significantly contribute to building lineage-specific transcriptomic atlas, which will be of an immense application to the developmental biologists and also for promoting the protocols for the derivation of selective lineages for the future cell replacement therapy. Finally, the identification of the TUFs by this approach in combination with 'loss of function' tools offers a new approach in elucidating the role of the TUFs during the differentiation processes.
Experimental procedures
Materials
All cell culture media, supplements, DNAse I and SuperscriptÔ II Reverse Transcriptase were purchased from Invitrogen (Karlsruhe, Germany). CGR8 ESCs were obtained from European Collection of Cell Cultures (ECACC), catalogue 95011018 (Genoa, Italy). The Brachyury BAC clone (RP23-376B1) and the ThermoScriptÔ Reverse Transcriptase were obtained from Invitrogen. The BAC subcloning kit was obtained from Gene Bridges, Dresden, Germany. Oligos for subcloning of the brachyury promoter were purchased from Metabion (Munich, Germany). Primary antibodies antibrachyury (catalogue ab20680) were from Abcam (Cambridge, UK). Anti-mouse IgG1-AlexaFluor488 and anti-rabbitIg-AlexaFluor647 were purchased from Molecular Probes (Invitrogen GmbH, Karlsruhe, Germany). The TaqMan Gene Expression Assays were purchased from Applied Biosystems (Foster City, CA, USA). The QIAGEN's RNeasy Total RNA Isolation kit was obtained from Qiagen GmbH (Hilden, Germany). The REDTaq ReadyMix was purchased by Sigma (Munich, Germany).
ESC Culture and differentiation of EBs
CGR8 ESCs were cultured without feeder cells in Glasgow Minimum Essential Medium supplemented with 10% FBS, 2 mM L-glutamine, 100 units ⁄ mL leukemia inhibitory factor and 50 lM b-mercaptoethanol (b-ME) in 0.2% gelatine-coated flasks as previously described (Gissel et al. 2005) . To induce differentiation, the hanging drop protocol was used as described earlier (Gissel et al. 2005) using the differentiation medium containing Iscove's Modified Dulbecco's Medium (IMDM), supplemented with 20% FCS, 1% nonessential amino acids (v ⁄ v), 2 mM L-glutamine and 100 lM b-ME). On day 2, the formed multicellular aggregates (EBs) were transferred to suspension. On day 3, the EBs were either treated with puromycin (5 lg ⁄ ml) for the first 48 h and then with 2 lg ⁄ ml for the subsequent 24 h or left without treatment for 3 days. On day 6, the EGFP-fluorescing EBs were trypsinized and used for either FACS analysis or RNA extraction or immunohistochemistry.
Subcloning of brachyury promoter in the ESCtargeting vector by BAC recombineering
Five-kilobase promoter region upstream of the translation initiation site of the brachyury gene was subcloned from a BAC into the ESC targeting construct pPuroIRES2 EGFP by a recombineering approach as described in Fig. S1 . Oligos with the following sequences GCT GAG TCT TCT CTG TCA TTT  AAA TTA GGC TCT GTC TCA GTT TGC CAT TCA  GAT CTT CAC AGC TTG TCT GTA AGC GGA TG and  CCT CCC GCC ACC CTC TCC ACC TTC CAG GAG  TCT TGA CTC CCT ACC CAA CAA GAT CTG CTC  TCC TGA GTA GGA CAA ATC were used to amplify the linear minimal vector containing ColE1 origin and Ampicillin resistance cassette. The linear amplified product was electroporated into the Escherichia coli harboring the BAC and induced to express Red ET proteins. The minimal vector containing the brachyury promoter was positively selected with ampicillin.
Vector constructs and cell line generation
The basic ESC targeting construct pPuro IRES2 EGFP was constructed as described previously (Doss et al. 2007a) . The minimal vector with brachyury promoter was digested with Bgl II to release the brachyury promoter, which is then ligated in Bgl II-digested 5¢ dephosphorylated pPuroIRES2 EGFP to get pT-bra p PuroIRES2 EGFP. This was then linearized with AfeI and electroporated into CGR8 ESC line with 500 lF and 240 V in a Bio-Rad (Munich, Germany) Gene PulserÔ. The transfected clones were selected by 400 lg ⁄ mL neomycin, and after selection, the clones were maintained with 200 lg ⁄ mL neomycin.
Confocal fluorescence microscopy
Brachyury-GFP EBs from day 3 to day 5 were washed twice with prewarmed phosphate buffered saline (PBS) just before analysis using fluorescence microscopy. EBs suspended in PBS were analyzed using a confocal microscope (LSM 510 META) on an inverted stand (Axiovert 200M, Carl-Zeiss, Jena, Germany) using the objective Plan-NEOFLUAR 10· and the appropriate filter set for GFP detection. Images were taken using Zeiss software LSM 5 version 3.5.
Immunohistochemistry
Puromycin-resistant and EGFP-fluorescing brachyury + cells obtained, as outlined in Fig. 1d , were plated on the fibronectin coated cover slips. After 24-h post-plating, fixation was carried out with 99% methanol. Blocking was carried out in 5% bovine serum albumin. Incubations with the primary antibodies anti-brachyury (Abcam, catalogue ab20680, polyclonal, 5 lg ⁄ ml) and anti-GFP (Millipore, Billerica, MA, USA, monoclonal, 1 : 500) were carried out overnight at 4°C in 1% bovine serum albumin. After extensive washing, secondary detection was carried out for 2 h at room temperature. Hoechst dye (Hoechst 33324, Molecular Probes, Carlsbad, CA) was used to stain nuclei. Samples were mounted using ProLong Gold mounting medium (Molecular Probes) and observed using a Zeiss Axiovert 200 fluorescence microscope.
Semiquantitative RT-PCR analysis
Total RNA was extracted using RNeasy Mini kit (Qiagen) with on-column DNase I (Qiagen) digestion according to the manufacturer's instructions. Five micrograms of total RNA was reverse transcribed using SuperScript II Reverse transcriptase (Invitrogen) with random primers according to the manufacturer's recommended protocol. PCR amplification was carried out using REDTaq ReadyMix (Sigma) with 0.4 lM each primer. GAPDH was used as an internal control. The following conditions were used: an initial denaturation at 95°C for 2 min, followed by 22-35 cycles of 30-s denaturation at 95°C, 30 s annealing at 60°C and 60 s of elongation at 72°C. A final extension at 72°C for 5 min was included. Electrophoretic separation of PCR products was carried out on 2% agarose gels with 0.001% ethidium bromide. The primer sequences are listed in the Table S5 .
Quantitative real-time PCR
Validation of the Affymetrix data was carried out by qPCR analysis using ABI Prism 7900HT Sequence Detection System (Applied Biosystems). An amount of 100 ng RNA each from every biological triplicate of brachyury ESCs, control EBs and brachyury + cells was reverse transcribed using ThermoScriptÔ Reverse Transcriptase (Invitrogen). Then real-time PCR was carried out in technical triplicates for every sample from three biologically independent experiments using TaqMan Gene Expression Assays from Applied Biosystems. The gene expression assays included for the validation were Sox17 (Mm00488363_m1), Bmp2 (Mm01340178_m1), NF-H (Mm01191456_m1), GAPDH (Mm99999915_g1) and Nanog (Mm02019550_s1). The threshold line is set in the exponential phase of the amplification, and the cycle at which the sample reaches this level is called the cycle threshold (C t ). Therefore, the lower the C t value is the more the gene is expressed. Averaged C t values of each qRT-PCR from the target gene were normalized with the average C t values of the housekeeping gene, GAPDH, that ran in the same reaction plate to get DC t value. An increase in DC t value by 1 unit corresponds to a twofold lowering of the expression level. The fold change was calculated by using the formula, fold change = 2 )(Ct gene1 ) Ct gene2) . The resulting fold change is expressed as percentage of the maximum.
Flow cytometry
Single cell suspension was prepared by trypsinization. Cell clumps were removed by passing through cell strainer cap of a round bottom tube from Falcon Ò (BD, Heidelberg, Germany). Propidium iodide (PI) staining (Sigma) was included to exclude dead cells. Acquisition of 10 000 live (PI negative) cells was made with FACscan (BD Biosciences), and the data analysis was carried out with CellQuest software (BD). The respective wild type EBs on the same day as the sample EBs were used as the control.
Affymetrix analysis
RNA was extracted from ESCs or EBs using the QIAGEN's RNeasy Total RNA Isolation kit. For the synthesis of doublestranded cDNA from 15 lg total RNA the cDNA synthesis system kit (Roche, Mannheim, Germany) has been used. Biotinylated cRNA was synthesized with Perkin-Elmer's nucleotide analogues using the Ambion's MEGAScript T7 kit. According to the standard Affymetrix protocol, 15 lg fragmented cRNA was hybridized for 16 h at 45°C. RNA preparations from three biologically independent experiments with three different conditions (day 0 ES, day 6 control EBs and day 6 puromycin treated EBs) were processed and hybridized on the Mouse Genome 430 Version 2 Array (Affymetrix) which includes 45 101 probe sets. After hybridization, arrays were washed and stained with streptavidin-phycoerythrin in the Affymetrix GeneChip Fluidics Station 450 and further scanned using the Affymetrix GeneChip Scanner 3000 7G. The image data were analyzed with GCOS 1.4 using Affymetrix default analysis settings and global scaling as normalization method. All chips passed our quality criteria. Comparability of the experiment conditions has been checked over all 45 101 probe sets after RMA normalization (Irizarry et al. 2003 ) by a principal component analysis using Partek Genomic Suite (6.3 beta) correlation as a dispersion matrix and normalized Eigenvector scaling.
Promoter analysis
The transcription factor binding site analysis was carried out on the promoters of the genes up-regulated in the brachyury + cells with the genes up-regulated in BMP-2 + cells and a-MHC + cells as reference sets (from our previous work) ( Doss et al. 2007a,b) . First, the transcripts up-regulated in the brachyury + cells compared to both ESCs and corresponding EBs were obtained using t-test with significance threshold 0.01 for false discovery rate. The transcripts which were differentially expressed between the ESCs and EBs were discarded. The same procedure was repeated for BMP-2 + and a-MHC + cells to obtain the BMP-2 + and a-MHC + -specific transcript lists. After mapping transcripts to genes and discarding 200 genes contained in more than one list, we had 105 genes in brachyury + -specific list, 266 genes in BMP-2 + -specific list and 584 genes in a-MHC + -specific list. The promoters of these genes were compared against each other with respect to transcription factor binding sites. For the source of binding motifs, we used the position weight matrices (PWMs) from Transfac (version 11.4) (Wingender et al. 1996) and Jaspar (Sandelin et al. 2004) databases. Promoters of size 2-kb upstream of the transcription start site were obtained from the UCSC Genome Browser database (Karolchik et al. 2008) . In case two promoters of the same gene had overlapped more than 1 kb, we discarded one of the promoters. Each PWM was scored in every promoter by taking the average of the three highest scoring hits within the promoter. A PWM was considered interesting if the proportion of promoters scoring over some threshold was significantly higher in the brachyury + list than in the other two lists combined. The threshold was optimized for the fold change in the proportion, while requiring the Bonferroni corrected hypergeometric P-value to be below 0.05.
Functional annotation
Differentially expressed genes were analyzed according to predefined pathways and functional categories annotated by KEGG (Kanehisa & Goto 2000) , BioCarta (BioCarta Pathways 2009) and GO using the DAVID bioinformatic resource (Dennis et al. 2003) . For an overrepresented GO or KEGG pathway, a cutoff P-value of 0.01 has been chosen. In general, it should be noted that one gene can participate in more than one KEGG or BioCarta pathway and GO category.
siRNA knockdown ON-TARGET plus Smart pool siRNA against Larp2 was purchased from Thermo Scientific Dharmacon, Lafayette, CO, USA. siRNA targeted against Anrd34b was purchased from Qiagen Inc. (Cat. no. SI00864199, against the target sequence ACGGAACAAATTAAGCAATTA). Brachyury ESCs or wild type cells (each 1 · 10 5 per well of 12-well plate) were cultured for 24 h before incubating with 100 nm siRNA and 1.0 lL Lipofectamine 2000 (Invitrogen) for optimal transfection Nontarget control siRNA was used as negative control for each assay. Hanging drop EBs were made 48 h postsiRNA transfection. EBs were harvested at regular daily intervals from day 0 to day 10, and the transcripts of interest were analyzed at the mRNA level by qRT-PCR.
Supporting Information/Supplementary Material
The following Supporting Information can be found in the online version of the article: Figure S1 Overview of the Bacterial Artificial Chromosomes (BAC) subcloning by recombineering approach (right scheme, slightly modified from the Gene Bridges BAC recommbineering manual) to subclone the brachyury promoter from the BAC and then to clone the promoter into Puro ⁄ EGFP IRES vector. Figure S2 Validation of Affymetrix data by quantitative realtime polymerase chain reaction (PCR) analyses. The fold change was calculated by using the formula: fold-change = 2 )(DCtgene1 ) DCtgene2) . DCt of the gene in the sample in which it is expressed lowest is taken as DCt gene2 to calculate the fold change using the above formula. The resulting fold change is expressed as percentage of the maximum fold change (= 100%) for that particular gene in every assay. Values are expressed as mean ± standard deviation (n = 3; technical replicates).
Transcriptome of brachyury + (T) cells Figure S3 Hierarchical clustering of the transcripts up-or downregulated in brachyury + cells in comparison to at least one of brachyury ESCs and the 6-days old control EBs. Figure S4 RT-PCR analysis for various developmental gene markers in ESCs and EBs treated with either siRNA against Ankrd34b or with vehicle of the siRNA. 
